Cyclophosphamide
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Cyclophosphamide
Jun 23, 2024, 06:27 |
Blog
Chibuike Okafor: Just Touching Some Anticancer Drugs Can Lead to Cancer
Chibuike Okafor, Online Tutor at Pristine eTutor, shared on LinkedIn: "Just Touching Some Anticancer Drugs Can…
Jun 10, 2024, 12:49 |
Dialogues
ASCO24 Updates: New Hope for Advanced Melanoma Patients: TIL Therapy Explained
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Jun 4, 2024, 16:28 |
Societies
Erika Hamilton: Data that pCR translates to outcome in TNBC
Erika Hamilton shared a post on X: “PEARLY: Adriamycin Cyclophosphamide (AC) to Taxane versus AC…
May 14, 2024, 16:12 |
Insight
Myeloma Paper of the Day, May 14th, suggester by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
Apr 10, 2024, 08:41 |
Drugs
Piotr Wysocki: CAR-T cells targeting CD70 for renal cell cancer – promising results of a phase I COBALT-RCC study (AACR2024)
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 3, 2024, 15:42 |
Drugs
Jarushka Naidoo: Phase II trial of Tumor-Infiltrating Lymphocyte (TIL) therapy (Lifileucel) in Advanced Non-Small Cell Lung Cancer post Immunotherapy with or without chemotherapy
Jul 23, 2023, 17:26 |
Drugs
Myeloma drugs - Dosing and schedule by Vincent Rajkumar on Twitter
Myeloma drugs — Dosing and schedule What I do in practice Dex: 40 mg…
All:
7
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube